3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like Innovia To Report Fourth Quarter And Full Year 2016 Financial Results On February 9, 2017 At 5:00 P.M. EST February 2, 2017 UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017 Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry January 18, 2017
Innovia To Report Fourth Quarter And Full Year 2016 Financial Results On February 9, 2017 At 5:00 P.M. EST February 2, 2017
UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017
Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry January 18, 2017
